Asthma

>

Latest News

Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma
Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma

October 7th 2024

Albuterol/budesonide (Airsupra) has now proven effective as novel combination as-needed rescue medication for adults with asthma regardless of disease severity.

States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence / Image credit: ©Alessandro Grandini/AdobeStock
States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence

July 9th 2024

Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes ©Crystal Light/stock.adobe.com
Find and Treat Asthma and COPD: All Interventions Make a Difference, Study Concludes

May 22nd 2024

©Oleksandr/stock.adobe.com via AI
AstraZeneca at ATS 2024: Look for Late-Breaking Data on Novel Therapeutics for COPD

May 8th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.